期刊文献+

染色体3p21.3缺失区域11个相关基因在非小细胞肺癌中的表达 被引量:5

The Expression Status of 11 Genes,Located at the Commonly Deleted Region 3p21.3,in Non-small Cell Lung Cancer
暂未订购
导出
摘要 背景与目的50%-80%的非小细胞肺癌存在染色体短臂3p21.3上等位基因的丢失,提示可能存在多个潜在的抑瘤基因。本研究通过大规模筛选3p21.3区相关基因在肺癌中的表达,以期找到数个肺癌相关抑瘤基因。方法应用生物信息学方法,选择出11个位于该区与肿瘤密切相关的基因,RT-PCR检测16例非小细胞肺癌及配对组织标本中11个基因的表达,并进行相关统计分析。结果在11个基因中,5个基因[RASSF1A43.8%(7/16),GNAT137.5%(6/16),SEMA3B62.5%(10/16),SEMA3F50%(8/16),Blu56.3%(9/16)]在非小细胞肺癌组织中表达下调或缺失(P<0.05);其余6个基因ZNF35、NPRL2、LTF、AXUD1、BAP1和FUS1的表达,在非小细胞肺癌及配对组织标本的表达无统计学差异。结论肺癌组织中3p21.3区有多个基因参与了肺癌的发生发展。 Background and objective The deletion of allele located at 3p21.3 region is found in 50%-80% of nonsmall cell lung cancer (NSCLC), suggesting that this region might harbor some tumor suppressor genes (TSGs). It is anticipated that some TSGs closely related to NSCLC carcinogenesis might be found by screening the expression of genes, located at the commonly deleted region 3p21.3, in NSCLC. Methods Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) and related statistical analysis were applied to examine the expression status of 11 genes closely related to tumor selected from 3p21.3 by bioinformatics in 16 NSCLC biopsies. Results No expression or down-regulation of RASSFIA, GNAT1, SEMA3B, SEMA3F, Blu were observed in 43.8% (7/16), 37.5% (6/16), 62.5% (10/16), 50% (8/16), 56.3% (9/16) respectively, in NSCLC tissues (P〈0.05). No difference was found in another six genes (ZNF35, NPRL2, LTF, AUXDI, BAP1 and FUS1) from 11 genes in NSCLC and matched tumor-adjacent normal tissues. Conclusion Several genes identified from 3p21.3 may play a certain role in NSCLC carcinogenesis.
出处 《中国肺癌杂志》 CAS 2009年第8期853-858,共6页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 基因表达 抑瘤基因 Lung neoplasms Gene expression Tumor suppressor genes (TSGs)
  • 相关文献

参考文献16

  • 1Senchenko VN, Liu J, Loginov W, et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene, 2004, 23(34): 5719-5728.
  • 2Hesson LB, Cooper WN, Latif F. Evaluation of the 3p21.3 tumor-suppressor gene cluster. Oncogene, 2007, 26 (52): 7283-7301.
  • 3Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene, 2002, 21(45): 6915-6935.
  • 4Sekido Y, Ahmadian M, Wistuba II, et al. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene, 1998, 16(24): 3151-3157.
  • 5Lerman MI, Minna JD. The 630-kb Lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res, 2000, 60(21); 6116-6133.
  • 6Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a Ras association domain family protein from the lung tumor suppressor locus 3p21.3. Nature Genet, 2000, 25 (3): 315-319.
  • 7Tomizawa Y, SekidoY, Kondo M, et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA, 2001, 98(24):13954-13959.
  • 8Tse C, Xiang RH, Bracht T, et al. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res, 2002, 62(2): 542-546.
  • 9Ochi K, Mori T, Toyama Y, et al. Identification of semaphorin3B as a direct target ofp53. Neoplasia, 2002, 4(1): 82-87.
  • 10Brambiila E, Constantin B, Drabkin H, et aI. Semaphorin SEMA3F localization in malignant Human lung and cell lines: A suggested role in cell adhesion and cell migration. AmJ Pathol, 2000, 156(3): 939-950.

二级参考文献4

共引文献6

同被引文献30

  • 1Chao Li,Shaoyuan Lei,Li Ding,Yan Xu,Xiaonan Wu,Hui Wang,Zijin Zhang,Ting Gao,Yongqiang Zhang,Lin Li.Global burden and trends of lung cancer incidence and mortality[J].Chinese Medical Journal,2023,136(13):1583-1590. 被引量:93
  • 2梅新宇,孙余婕,徐美青,马冬春,魏大中,田界勇,任自学.非小细胞肺癌3p染色体多区域杂合性缺失检测的研究[J].中国肺癌杂志,2008,11(4):534-537. 被引量:3
  • 3易红梅,任彩萍,彭丹,周亮,李辉,姚开泰.鼻咽癌组织中GNAT1基因的表达、杂合性丢失及甲基化分析[J].癌症,2007,26(1):9-14. 被引量:7
  • 4Kost- Alimova M, Imreh S. Modeling non -random deletions in cancer[ J ]. Semin Cancer Biol, 2007,17 ( 1 ) : 19 - 30.
  • 5Metz- Boutigue MH, Jolles J, Mazurier J, et al. Human lactotrans- ferrin: amino acid sequence and structural comparisons with other-transferrins[ J]. Eur J Biochem, 1984,145 (3) :659 - 676.
  • 6Querinjean P, Masson PL, Heremans JF. Molecular weight, single - chain structure and amino acid composition of humanlactoferrin [ J ]. Eur J Biochem, 1971,20(3) :420 -425.
  • 7lyer S, Lonnerdal B. Lactoferrin, lactoferrin receptors and iron me- tabolism[J]. Eur J Clin Nutr, 1993,47(4) :232 -241.
  • 8Levay PF, Viljoen M. Lactoferrin : a general review[ J]. Haematolog- ica, 1995,80(3) :252 -267.
  • 9Bezault J, Bhimani R, Wiprovnick J, et al. Human lactoferrin inhib- its growth of solid tumors and development of experimentalmetastases in mice[J]. CancerRes, 1994,54(9) :2310 -2312.
  • 10Shaheduzzaman S, Vishwanath A, Furusato B, et al. Silencing of Lactotransferrin expression by methylation in prostate cancerprogres- sion [ J ]. Cancer Biol Ther, 2007,6 (7) : 1088 - 1095.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部